Functional Lipid Nanosystems in Cancer
portes grátis
Functional Lipid Nanosystems in Cancer
Real Oliveira, Maria Elisabete C.D.; Lucio, Marlene; Lopes, Carla M.
Jenny Stanford Publishing
11/2021
712
Dura
Inglês
9789814877268
15 a 20 dias
1047
Descrição não disponível.
Part 1: General Aspects of Cancer Pathology and Treament Options 1. Physiological Barriers in Cancer: A Challenge to Be Overcome 2. Cancer Chemotherapy, Bioactive Compounds, and Immunotherapy Part 2: General Aspects of Functional Lipid Nanotherapy 3. General Aspects of a Multifunctional Nanosystem Part 3: Multifunctional Lipid Nanosystems for Cancer: Research Highlights 4. Co-delivery of Anticancer Therapeutics via Lipid-Based Nanoscale Delivery Systems 5. Lipid-Based Nanocarriers for Co-delivery of Anticancer Drugs and Natural Compounds 6. Co-delivery of Anticancer Drug and Adjuvant Agents 7. Hybrid Nanosystems Composed by Lipid and Polymer Materials 8. Lipid Nanosystems: Targeted Nano-delivery of Therapeutic Agents in Treatment of Cancer 9. Monoclonal Antibody Ligands for Liposomes Functionalization: Immunoliposomes Formulation and Clinical Status 10. Active Targeting for Tumor Microenvironment: Integrin Binding Peptides 11. Targeting Liposomes to Metastatic Tumors with Antibodies Specific for VCAM-1 12. Active Targeting: Mitochondria-Targeting Signal Peptides 13. Recent Developments of Light: Triggered Liposome Nanosystems for Cancer Treatments 14. Ultrasound-Responsive Nanosystems 15. Lipid-Based Nanosystems for Gene and Drug Co-delivery in Cancer Therapy 16. The Therapeutical Window of Light: Modulating Receptor Proteins and Metabolic Pathways with Light and Its Importance for Disease Control 17. Magnetic Lipid-Based Nanosystems for Combined Therapy of Cancer
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Tumor Microenvironment;Drug Release;PEGylated Liposome;Delivery Systems;Cancer Cells;Lipid Bilayer;Co-delivery System;pH Sensitive Liposomes;Chemotherapeutic Agents;Cholesteryl Hemisuccinate;CHEMS;Drug Delivery Systems;Cationic Liposomes;Polymer Lipid Hybrid;Nontargeted Liposomes;Classical Anticancer Drugs;Hybrid Nanosystems;PLNPs;Phase Transition Temperature;Nano Drug Delivery System;SLNs;Encapsulation Efficiency;DSPC;LUVs;DOPC
Part 1: General Aspects of Cancer Pathology and Treament Options 1. Physiological Barriers in Cancer: A Challenge to Be Overcome 2. Cancer Chemotherapy, Bioactive Compounds, and Immunotherapy Part 2: General Aspects of Functional Lipid Nanotherapy 3. General Aspects of a Multifunctional Nanosystem Part 3: Multifunctional Lipid Nanosystems for Cancer: Research Highlights 4. Co-delivery of Anticancer Therapeutics via Lipid-Based Nanoscale Delivery Systems 5. Lipid-Based Nanocarriers for Co-delivery of Anticancer Drugs and Natural Compounds 6. Co-delivery of Anticancer Drug and Adjuvant Agents 7. Hybrid Nanosystems Composed by Lipid and Polymer Materials 8. Lipid Nanosystems: Targeted Nano-delivery of Therapeutic Agents in Treatment of Cancer 9. Monoclonal Antibody Ligands for Liposomes Functionalization: Immunoliposomes Formulation and Clinical Status 10. Active Targeting for Tumor Microenvironment: Integrin Binding Peptides 11. Targeting Liposomes to Metastatic Tumors with Antibodies Specific for VCAM-1 12. Active Targeting: Mitochondria-Targeting Signal Peptides 13. Recent Developments of Light: Triggered Liposome Nanosystems for Cancer Treatments 14. Ultrasound-Responsive Nanosystems 15. Lipid-Based Nanosystems for Gene and Drug Co-delivery in Cancer Therapy 16. The Therapeutical Window of Light: Modulating Receptor Proteins and Metabolic Pathways with Light and Its Importance for Disease Control 17. Magnetic Lipid-Based Nanosystems for Combined Therapy of Cancer
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Tumor Microenvironment;Drug Release;PEGylated Liposome;Delivery Systems;Cancer Cells;Lipid Bilayer;Co-delivery System;pH Sensitive Liposomes;Chemotherapeutic Agents;Cholesteryl Hemisuccinate;CHEMS;Drug Delivery Systems;Cationic Liposomes;Polymer Lipid Hybrid;Nontargeted Liposomes;Classical Anticancer Drugs;Hybrid Nanosystems;PLNPs;Phase Transition Temperature;Nano Drug Delivery System;SLNs;Encapsulation Efficiency;DSPC;LUVs;DOPC
